value_set_oid,value_set_name,value_set_version
1.3.6.1.4.1.33895.1.3.0.45,Comfort Measures ,20140401
2.16.840.1.113762.1.4.1021.10,Warfarin-only ingredient specific,20140401
2.16.840.1.113762.1.4.1021.11,Injectable factor Xa inhibitor for VTE prophylaxis ingredient specific,20140401
2.16.840.1.113762.1.4.1021.12,Low Molecular Weight Heparin for VTE prophylaxis ingredient specific,20140401
2.16.840.1.113762.1.4.1021.13,Unfractionated Heparin for VTE prophylaxis ingredient specific,20140401
2.16.840.1.113762.1.4.1021.3,Aspirin ingredient specific,20140401
2.16.840.1.113762.1.4.1021.4,Parenteral anticoagulant ingredient specific,20140401
2.16.840.1.113762.1.4.1021.6,t-PA ingredient specific,20140401
2.16.840.1.113762.1.4.1021.7,Statin ingredient specific,20140401
2.16.840.1.113762.1.4.1021.8,Antithrombotic ingredient specific,20140401
2.16.840.1.113762.1.4.1021.9,Anticoagulant ingredient specific,20140401
2.16.840.1.113762.1.4.1045.14,Time of Symptom Onset,20140401
2.16.840.1.113762.1.4.1045.15,Intravenous Thrombolytic (t-PA) Therapy,20140401
2.16.840.1.113762.1.4.1045.18,Rehabilitation Assessment,20140401
2.16.840.1.113762.1.4.1045.19,Rehabilitation Therapy,20140401
2.16.840.1.113762.1.4.1045.21,Intravenous or Intra-arterial Thrombolytic (t-PA) Therapy,20140401
2.16.840.1.113762.1.4.1045.24,Prothrombin Time,20140401
2.16.840.1.113762.1.4.1045.25,Partial Thromboplastin Time,20140401
2.16.840.1.113762.1.4.1045.26,Estimated Gestational Age at Delivery,20140401
2.16.840.1.113762.1.4.1045.27,Cornual Ectopic Pregnancy,20140401
2.16.840.1.113762.1.4.1045.28,Time of Delivery,20140401
2.16.840.1.113762.1.4.1045.29,Feeding Intention-Breast,20140401
2.16.840.1.113762.1.4.1045.31,Other Anticoagulants for AMI,20140401
2.16.840.1.113762.1.4.1045.32,Hospital Measures-PACU,20140401
2.16.840.1.113762.1.4.1045.36,NSTEMI,20140401
2.16.840.1.113762.1.4.1045.39,Low Dose Unfractionated Heparin for VTE Prophylaxis,20140401
2.16.840.1.113762.1.4.1045.3,IV Ceftriaxone,20140401
2.16.840.1.113762.1.4.1045.41,Glycoprotein IIb/IIIa Inhibitors,20140401
2.16.840.1.113762.1.4.1045.45,Thrombocytopenia,20140401
2.16.840.1.113762.1.4.1045.47,Estimated Gestational Age at Birth,20140401
2.16.840.1.113762.1.4.1045.52,Laparoscopic Procedures,20140401
2.16.840.1.113762.1.4.1045.55,Oxytocin,20140401
2.16.840.1.113762.1.4.1045.56,Dinoprostone,20140401
2.16.840.1.113762.1.4.1045.57,Artificial Rupture of Membranes,20140401
2.16.840.1.113762.1.4.1045.5,IM or PO Antimicrobial medications,20140401
2.16.840.1.113762.1.4.1045.67,PCI,20140401
2.16.840.1.113762.1.4.1045.69,Endotrachael Intubation,20140401
2.16.840.1.113762.1.4.1045.6,IM or PO route,20140401
2.16.840.1.113762.1.4.1045.74,Indwelling urinary catheter,20140401
2.16.840.1.113762.1.4.1045.77,Tracheostomy care,20140401
2.16.840.1.113762.1.4.1045.7,IV Cefazolin,20140401
2.16.840.1.113762.1.4.1045.84,Reason For Admission to ICU due to Pneumonia,20140401
2.16.840.1.113762.1.4.1045.8,IV Cefuroxime,20140401
2.16.840.1.113762.1.4.1046.6,Liveborn Newborn Born in Hospital,20140401
2.16.840.1.113762.1.4.1078.5,Delivery - Procedure,20140701
2.16.840.1.113762.1.4.1080.2,Face to Face Interaction - No ED,20140701
2.16.840.1.113762.1.4.1,ONC Administrative Sex,20140530
2.16.840.1.113883.3.117.1.7.1.131,Asthma Management Plan,20140401
2.16.840.1.113883.3.117.1.7.1.132,Discharged to Rehabilitation Facility,20140401
2.16.840.1.113883.3.117.1.7.1.134,Oral Factor Xa Inhibitor for VTE Prophylaxis,20140401
2.16.840.1.113883.3.117.1.7.1.136,Perforation of Uterus,20140401
2.16.840.1.113883.3.117.1.7.1.137,Uterine Window,20140401
2.16.840.1.113883.3.117.1.7.1.138,Uterine Rupture,20140401
2.16.840.1.113883.3.117.1.7.1.139,Aspirin Allergen,20140401
2.16.840.1.113883.3.117.1.7.1.14,Principal,20140701
2.16.840.1.113883.3.117.1.7.1.200,Anticoagulant Therapy,20140401
2.16.840.1.113883.3.117.1.7.1.201,Antithrombotic Therapy,20140401
2.16.840.1.113883.3.117.1.7.1.202,Atrial Fibrillation/Flutter,20140701
2.16.840.1.113883.3.117.1.7.1.203,Atrial Ablation,20140401
2.16.840.1.113883.3.117.1.7.1.205,Direct Thrombin Inhibitor,20140401
2.16.840.1.113883.3.117.1.7.1.207,Discharged to Health Care Facility for Hospice Care,20140401
2.16.840.1.113883.3.117.1.7.1.209,Discharged to Home for Hospice Care,20140401
2.16.840.1.113883.3.117.1.7.1.211,Injectable Factor Xa Inhibitor for VTE Prophylaxis,20140401
2.16.840.1.113883.3.117.1.7.1.212,Hemorrhagic Stroke,20140401
2.16.840.1.113883.3.117.1.7.1.213,INR,20140701
2.16.840.1.113883.3.117.1.7.1.214,Intermittent pneumatic compression devices (IPC),20140401
2.16.840.1.113883.3.117.1.7.1.215,LDL-c,20140401
2.16.840.1.113883.3.117.1.7.1.217,Lipid-lowering Agent,20140401
2.16.840.1.113883.3.117.1.7.1.218,Unfractionated Heparin,20140401
2.16.840.1.113883.3.117.1.7.1.219,Low Molecular Weight Heparin for VTE Prophylaxis,20140401
2.16.840.1.113883.3.117.1.7.1.222,Intravenous route,20140401
2.16.840.1.113883.3.117.1.7.1.223,Subcutaneous route,20140401
2.16.840.1.113883.3.117.1.7.1.225,Statin,20140401
2.16.840.1.113883.3.117.1.7.1.226,Thrombolytic (t-PA) Therapy,20140401
2.16.840.1.113883.3.117.1.7.1.230,Venous foot pumps (VFP),20140401
2.16.840.1.113883.3.117.1.7.1.232,Warfarin,20140701
2.16.840.1.113883.3.117.1.7.1.247,Ischemic Stroke,20140401
2.16.840.1.113883.3.117.1.7.1.253,Clinical Pathway Protocol,20140401
2.16.840.1.113883.3.117.1.7.1.255,General Surgery,20140401
2.16.840.1.113883.3.117.1.7.1.256,Graduated compression stockings (GCS),20140401
2.16.840.1.113883.3.117.1.7.1.257,Gynecological Surgery,20140401
2.16.840.1.113883.3.117.1.7.1.258,Hip Fracture Surgery,20140401
2.16.840.1.113883.3.117.1.7.1.259,Hip Replacement Surgery,20140401
2.16.840.1.113883.3.117.1.7.1.25,Single Live Birth,20140401
2.16.840.1.113883.3.117.1.7.1.260,Intracranial Neurosurgery,20140401
2.16.840.1.113883.3.117.1.7.1.261,Knee Replacement Surgery,20140401
2.16.840.1.113883.3.117.1.7.1.262,Mental Disorders,20140401
2.16.840.1.113883.3.117.1.7.1.263,Obstetrics,20140401
2.16.840.1.113883.3.117.1.7.1.264,Obstetrics VTE,20140401
2.16.840.1.113883.3.117.1.7.1.266,Parenteral Anticoagulant,20140401
2.16.840.1.113883.3.117.1.7.1.267,Platelet Count,20140401
2.16.840.1.113883.3.117.1.7.1.269,National Institute of Health Stroke Scale,20140401
2.16.840.1.113883.3.117.1.7.1.26,Single Liveborn Newborn Born in Hospital,20140401
2.16.840.1.113883.3.117.1.7.1.271,Asthma,20140401
2.16.840.1.113883.3.117.1.7.1.272,Urological Surgery,20140401
2.16.840.1.113883.3.117.1.7.1.276,VTE Diagnostic Test,20140401
2.16.840.1.113883.3.117.1.7.1.277,VTE Suspected,20140401
2.16.840.1.113883.3.117.1.7.1.278,Treatment Adjusted by Protocol,20140401
2.16.840.1.113883.3.117.1.7.1.279,Venous Thromboembolism,20140401
2.16.840.1.113883.3.117.1.7.1.27,Dietary Intake Other than Breast Milk,20140401
2.16.840.1.113883.3.117.1.7.1.281,Labor,20140401
2.16.840.1.113883.3.117.1.7.1.282,Cesarean Section,20140401
2.16.840.1.113883.3.117.1.7.1.286,Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation,20140401
2.16.840.1.113883.3.117.1.7.1.288,Medical Induction of Labor,20140401
2.16.840.1.113883.3.117.1.7.1.292,Emergency Department Visit,20140401
2.16.840.1.113883.3.117.1.7.1.295,Decision to Admit to Hospital Inpatient,20140401
2.16.840.1.113883.3.117.1.7.1.299,Psychiatric/Mental Health Patient,20140401
2.16.840.1.113883.3.117.1.7.1.2,SCIP Major Surgical Procedure,20140401
2.16.840.1.113883.3.117.1.7.1.301,Medication Compliance Education,20140401
2.16.840.1.113883.3.117.1.7.1.302,Vitamin K Dietary Management,20140401
2.16.840.1.113883.3.117.1.7.1.303,Follow-up Monitoring,20140401
2.16.840.1.113883.3.117.1.7.1.304,Adverse Drug Reactions Education,20140401
2.16.840.1.113883.3.117.1.7.1.305,ICU Admission or Transfer,20140401
2.16.840.1.113883.3.117.1.7.1.308,Left Against Medical Advice,20140401
2.16.840.1.113883.3.117.1.7.1.309,Patient Expired,20140401
2.16.840.1.113883.3.117.1.7.1.30,Breast Milk,20140401
2.16.840.1.113883.3.117.1.7.1.357,VTE Risk Assessment,20140401
2.16.840.1.113883.3.117.1.7.1.35,Galactosemia,20140401
2.16.840.1.113883.3.117.1.7.1.372,Complication Mainly Related to Pregnancy,20140401
2.16.840.1.113883.3.117.1.7.1.375,Complication of the Puerperium,20140401
2.16.840.1.113883.3.117.1.7.1.377,Activation of Emergency Medical System Education,20140401
2.16.840.1.113883.3.117.1.7.1.378,Instructions for Follow Up After Discharge,20140401
2.16.840.1.113883.3.117.1.7.1.379,Prescribed Medications Education,20140401
2.16.840.1.113883.3.117.1.7.1.380,Risk Factors Education,20140401
2.16.840.1.113883.3.117.1.7.1.381,Warning Signs and Symptoms Education,20140401
2.16.840.1.113883.3.117.1.7.1.38,Parenteral Infusion,20140401
2.16.840.1.113883.3.117.1.7.1.391,Normal Delivery and Other Indications for Care,20140401
2.16.840.1.113883.3.117.1.7.1.397,Complication Mainly in the Course of Labor and Delivery,20140401
2.16.840.1.113883.3.117.1.7.1.400,Low Risk,20140401
2.16.840.1.113883.3.117.1.7.1.401,Delivery Procedures,20140401
2.16.840.1.113883.3.117.1.7.1.407,VTE Confirmed,20140401
2.16.840.1.113883.3.117.1.7.1.412,Medical Contraindication,20140401
2.16.840.1.113883.3.117.1.7.1.413,Recommendation not to change diet,20140401
2.16.840.1.113883.3.117.1.7.1.414,Drug Interactions Education,20140401
2.16.840.1.113883.3.117.1.7.1.415,Written Information Given,20140401
2.16.840.1.113883.3.117.1.7.1.416,INR Monitoring Education,20140401
2.16.840.1.113883.3.117.1.7.1.417,Baseline State,20140401
2.16.840.1.113883.3.117.1.7.1.421,Classical Cesarean Section,20140401
2.16.840.1.113883.3.117.1.7.1.422,Myomectomy,20140401
2.16.840.1.113883.3.117.1.7.1.423,Statin Allergen,20140401
2.16.840.1.113883.3.117.1.7.1.424,Non-Elective Inpatient Encounter,20140401
2.16.840.1.113883.3.117.1.7.1.473,Medical Reason,20140401
2.16.840.1.113883.3.117.1.7.1.70,Birth,20140401
2.16.840.1.113883.3.117.1.7.1.75,Neonatal Intensive Care Unit (NICU),20140401
2.16.840.1.113883.3.117.1.7.1.799,LDL-c Test,20140401
2.16.840.1.113883.3.117.1.7.1.82,Discharge To Home Or Police Custody,20140401
2.16.840.1.113883.3.117.1.7.1.87,Discharge To Another Hospital,20140401
2.16.840.1.113883.3.117.1.7.1.93,Patient Refusal,20140401
2.16.840.1.113883.3.1257.1.1504,BH Condition Involving Bipolar Disorder,20140701
2.16.840.1.113883.3.1257.1.1505,BH Condition Involving Unipolar Depression,20140701
2.16.840.1.113883.3.1257.1.1533,BH Electroconvulsive Therapy,20140701
2.16.840.1.113883.3.1257.1.1604,BH Assessment for Alcohol or Other Drugs,20140701
2.16.840.1.113883.3.1257.1.1616,BH Counseling for Depression,20140701
2.16.840.1.113883.3.1257.1.1652,BH Medical or psychiatric consultation,20140701
2.16.840.1.113883.3.1257.1.950,BH Mood Stabilizer Medication,20140701
2.16.840.1.113883.3.1257.1.972,BH Antidepressant Medication,20140701
2.16.840.1.113883.3.1257.1.973,BH Outpatient Psychotherapy,20140701
2.16.840.1.113883.3.464.1003.101.12.1001,Office Visit,20140530
2.16.840.1.113883.3.464.1003.101.12.1002,Hospital Observation Care - Initial,20140701
2.16.840.1.113883.3.464.1003.101.12.1004,Hospital Inpatient Visit - Initial,20140701
2.16.840.1.113883.3.464.1003.101.12.1006,Discharge Services - Hospital Inpatient Same Day Discharge,20140701
2.16.840.1.113883.3.464.1003.101.12.1007,Discharge Services - Hospital Inpatient,20140701
2.16.840.1.113883.3.464.1003.101.12.1008,Outpatient Consultation,20140701
2.16.840.1.113883.3.464.1003.101.12.1010,Emergency Department Visit,20140701
2.16.840.1.113883.3.464.1003.101.12.1012,Nursing Facility Visit,20140701
2.16.840.1.113883.3.464.1003.101.12.1013,Discharge Services - Nursing Facility,20140701
2.16.840.1.113883.3.464.1003.101.12.1014,Care Services in Long-Term Residential Facility,20140701
2.16.840.1.113883.3.464.1003.101.12.1016,Home Healthcare Services,20140530
2.16.840.1.113883.3.464.1003.101.12.1022,"Preventive Care- Initial Office Visit, 0 to 17",20140701
2.16.840.1.113883.3.464.1003.101.12.1023,"Preventive Care Services-Initial Office Visit, 18 and Up",20140530
2.16.840.1.113883.3.464.1003.101.12.1024,"Preventive Care - Established Office Visit, 0 to 17",20140701
2.16.840.1.113883.3.464.1003.101.12.1025,"Preventive Care Services - Established Office Visit, 18 and Up",20140530
2.16.840.1.113883.3.464.1003.101.12.1026,Preventive Care Services-Individual Counseling,20140701
2.16.840.1.113883.3.464.1003.101.12.1027,Preventive Care Services - Group Counseling,20140701
2.16.840.1.113883.3.464.1003.101.12.1030,Preventive Care Services - Other,20140701
2.16.840.1.113883.3.464.1003.101.12.1031,Telehealth Services,20140701
2.16.840.1.113883.3.464.1003.101.12.1039,Discharge Services- Observation Care,20140701
2.16.840.1.113883.3.464.1003.101.12.1046,Referral,20140701
2.16.840.1.113883.3.464.1003.101.12.1047,HIV Visit,20140701
2.16.840.1.113883.3.464.1003.101.12.1048,Face-to-Face Interaction,20140530
2.16.840.1.113883.3.464.1003.101.12.1053,Telephone Management,20140701
2.16.840.1.113883.3.464.1003.101.12.1054,Behavioral Health Follow-up Visit,20140701
2.16.840.1.113883.3.464.1003.101.12.1055,Psychotherapy and Pharmacologic Management,20140701
2.16.840.1.113883.3.464.1003.101.12.1056,Blood Pressure Visit,20140701
2.16.840.1.113883.3.464.1003.101.12.1059,Detoxification Visit,20140701
2.16.840.1.113883.3.464.1003.101.12.1060,Inpatient Encounter,20140701
2.16.840.1.113883.3.464.1003.101.12.1061,Ambulatory/ED Visit,20140701
2.16.840.1.113883.3.464.1003.102.12.1002,Cystic Fibrosis,20140701
2.16.840.1.113883.3.464.1003.102.12.1004,Emphysema,20140701
2.16.840.1.113883.3.464.1003.102.12.1007,Chronic Obstructive Pulmonary Disease,20140701
2.16.840.1.113883.3.464.1003.102.12.1011,Acute Pharyngitis,20140701
2.16.840.1.113883.3.464.1003.102.12.1012,Acute Tonsillitis,20140701
2.16.840.1.113883.3.464.1003.102.12.1017,Competing Conditions for Respiratory Conditions,20140701
2.16.840.1.113883.3.464.1003.102.12.1018,Acute Respiratory Failure,20140701
2.16.840.1.113883.3.464.1003.102.12.1022,Upper Respiratory Infection,20140701
2.16.840.1.113883.3.464.1003.102.12.1023,Persistent Asthma,20140701
2.16.840.1.113883.3.464.1003.103.12.1001,Diabetes,20140530
2.16.840.1.113883.3.464.1003.103.12.1012,Diabetes Visit,20140701
2.16.840.1.113883.3.464.1003.103.12.1013,Visual Exam of Foot,20140701
2.16.840.1.113883.3.464.1003.103.12.1014,Sensory Exam of Foot,20140701
2.16.840.1.113883.3.464.1003.103.12.1015,Pulse Exam of Foot,20140701
2.16.840.1.113883.3.464.1003.104.12.1001,Acute Myocardial Infarction,20140701
2.16.840.1.113883.3.464.1003.104.12.1002,Coronary Artery Bypass Graft,20140701
2.16.840.1.113883.3.464.1003.104.12.1003,Ischemic Vascular Disease,20140701
2.16.840.1.113883.3.464.1003.104.12.1010,Percutaneous Coronary Interventions,20140701
2.16.840.1.113883.3.464.1003.104.12.1011,Essential Hypertension,20140701
2.16.840.1.113883.3.464.1003.104.12.1012,HDL-C Laboratory Test,20140701
2.16.840.1.113883.3.464.1003.104.12.1013,Total Cholesterol Laboratory Test,20140701
2.16.840.1.113883.3.464.1003.104.12.1014,Triglycerides Laboratory Test,20140701
2.16.840.1.113883.3.464.1003.104.12.1017,Valvular Heart Disease,20140701
2.16.840.1.113883.3.464.1003.104.12.1018,Computed Value INR percent TTR,20140701
2.16.840.1.113883.3.464.1003.105.12.1004,Mental Health Diagnoses,20140701
2.16.840.1.113883.3.464.1003.105.12.1007,Major Depression,20140701
2.16.840.1.113883.3.464.1003.106.12.1001,Alcohol and Drug Dependence,20140701
2.16.840.1.113883.3.464.1003.106.12.1003,IV Drug Abuse,20140701
2.16.840.1.113883.3.464.1003.106.12.1004,Substance Abuse,20140701
2.16.840.1.113883.3.464.1003.106.12.1005,Alcohol and Drug Dependence Treatment,20140701
2.16.840.1.113883.3.464.1003.108.12.1001,Malignant Neoplasm of Colon,20140701
2.16.840.1.113883.3.464.1003.108.12.1009,Malignant Neoplasm of Lymphatic and Hematopietic Tissue,20140701
2.16.840.1.113883.3.464.1003.108.12.1011,All Cancer,20140701
2.16.840.1.113883.3.464.1003.108.12.1017,Pap Test,20140701
2.16.840.1.113883.3.464.1003.108.12.1018,Mammogram,20140701
2.16.840.1.113883.3.464.1003.108.12.1020,Colonoscopy,20140701
2.16.840.1.113883.3.464.1003.109.12.1004,Diabetic Nephropathy,20140701
2.16.840.1.113883.3.464.1003.109.12.1005,Microalbumin Test,20140701
2.16.840.1.113883.3.464.1003.109.12.1011,Vascular Access for Dialysis,20140701
2.16.840.1.113883.3.464.1003.109.12.1012,Kidney Transplant,20140701
2.16.840.1.113883.3.464.1003.109.12.1013,Dialysis Services,20140701
2.16.840.1.113883.3.464.1003.109.12.1014,ESRD Monthly Outpatient Services,20140701
2.16.840.1.113883.3.464.1003.109.12.1015,Other Services Related to Dialysis,20140701
2.16.840.1.113883.3.464.1003.109.12.1016,Dialysis Education,20140701
2.16.840.1.113883.3.464.1003.109.12.1017,Hypertensive Chronic Kidney Disease,20140701
2.16.840.1.113883.3.464.1003.109.12.1018,Glomerulonephritis and Nephrotic Syndrome,20140701
2.16.840.1.113883.3.464.1003.109.12.1019,Macroalbumin Test,20140701
2.16.840.1.113883.3.464.1003.110.12.1022,DTaP Vaccine Administered,20140701
2.16.840.1.113883.3.464.1003.110.12.1024,Hepatitis A,20140701
2.16.840.1.113883.3.464.1003.110.12.1025,Hepatitis B,20140701
2.16.840.1.113883.3.464.1003.110.12.1027,Pneumococcal Vaccine,20140701
2.16.840.1.113883.3.464.1003.110.12.1028,History of Pneumococcal Vaccine,20140701
2.16.840.1.113883.3.464.1003.110.12.1031,"Measles, Mumps and Rubella (MMR) Vaccine Administered",20140701
2.16.840.1.113883.3.464.1003.110.12.1032,Mumps,20140701
2.16.840.1.113883.3.464.1003.110.12.1034,Pneumococcal Vaccine Administered,20140701
2.16.840.1.113883.3.464.1003.110.12.1037,Rubella,20140701
2.16.840.1.113883.3.464.1003.110.12.1039,Varicella Zoster,20140701
2.16.840.1.113883.3.464.1003.110.12.1040,Varicella Zoster Vaccine (VZV) Administered,20140701
2.16.840.1.113883.3.464.1003.110.12.1041,Hepatitis A Vaccine Administered,20140701
2.16.840.1.113883.3.464.1003.110.12.1042,Hepatitis B Vaccine Administered,20140701
2.16.840.1.113883.3.464.1003.110.12.1043,Hemophilus Influenze B (HiB) Vaccine Administered,20140701
2.16.840.1.113883.3.464.1003.110.12.1044,Influenza Vaccine Administered,20140701
2.16.840.1.113883.3.464.1003.110.12.1045,Inactivated Polio Vaccine (IPV) Administered,20140701
2.16.840.1.113883.3.464.1003.110.12.1046,Pneumococcal Conjugate Vaccine Administered,20140701
2.16.840.1.113883.3.464.1003.110.12.1047,Rotavirus Vaccine (3 dose schedule) Administered,20140701
2.16.840.1.113883.3.464.1003.110.12.1048,Rotavirus Vaccine (2 dose schedule) Administered,20140701
2.16.840.1.113883.3.464.1003.110.12.1049,Genital Herpes,20140701
2.16.840.1.113883.3.464.1003.110.12.1051,Lab Tests for Sexually Transmitted Infections,20140701
2.16.840.1.113883.3.464.1003.110.12.1052,Chlamydia Screening,20140701
2.16.840.1.113883.3.464.1003.110.12.1053,Measles,20140701
2.16.840.1.113883.3.464.1003.110.12.1054,Seropositive,20140701
2.16.840.1.113883.3.464.1003.111.12.1006,Other Female Reproductive Conditions,20140701
2.16.840.1.113883.3.464.1003.111.12.1007,Lab Tests During Pregnancy,20140701
2.16.840.1.113883.3.464.1003.111.12.1008,Diagnostic Studies During Pregnancy,20140701
2.16.840.1.113883.3.464.1003.111.12.1009,Procedures During Pregnancy,20140701
2.16.840.1.113883.3.464.1003.111.12.1010,Procedures Involving Contraceptive Devices,20140701
2.16.840.1.113883.3.464.1003.111.12.1011,Pregnancy Test,20140701
2.16.840.1.113883.3.464.1003.111.12.1012,"Complications of Pregnancy, Childbirth and the Puerperium",20140701
2.16.840.1.113883.3.464.1003.111.12.1013,Maternal Post Partum Depression Care,20140701
2.16.840.1.113883.3.464.1003.111.12.1014,Maternal Post Partum Depression Screening,20140701
2.16.840.1.113883.3.464.1003.111.12.1015,Delivery Live Births,20140701
2.16.840.1.113883.3.464.1003.112.12.1001,Gonococcal Infections and Venereal Diseases,20140701
2.16.840.1.113883.3.464.1003.112.12.1002,Syphilis,20140701
2.16.840.1.113883.3.464.1003.112.12.1003,Chlamydia,20140701
2.16.840.1.113883.3.464.1003.112.12.1004,Inflammatory Diseases of Female Reproductive Organs,20140701
2.16.840.1.113883.3.464.1003.113.12.1001,Low Back Pain,20140701
2.16.840.1.113883.3.464.1003.113.12.1033,X-Ray of Lower Spine,20140701
2.16.840.1.113883.3.464.1003.113.12.1034,MRI of Lower Spine,20140701
2.16.840.1.113883.3.464.1003.113.12.1035,CT Scan of Lower Spine,20140701
2.16.840.1.113883.3.464.1003.113.12.1036,Trauma,20140701
2.16.840.1.113883.3.464.1003.113.12.1037,Fracture - Lower Body,20140701
2.16.840.1.113883.3.464.1003.114.12.1007,Encephalopathy,20140701
2.16.840.1.113883.3.464.1003.114.12.1011,Narcolepsy,20140701
2.16.840.1.113883.3.464.1003.114.12.1012,Neurologic impairment,20140701
2.16.840.1.113883.3.464.1003.115.12.1088,Retinal or Dilated Eye Exam,20140701
2.16.840.1.113883.3.464.1003.118.12.1009,Patient not ambulatory,20140701
2.16.840.1.113883.3.464.1003.118.12.1028,Falls Screening,20140701
2.16.840.1.113883.3.464.1003.118.12.1029,Functional Status Assessment  for Hip Replacement,20140701
2.16.840.1.113883.3.464.1003.118.12.1030,Functional Status Assessment for Knee Replacement,20140701
2.16.840.1.113883.3.464.1003.118.12.1031,Functional Status Assessment for Heart Failure,20140701
2.16.840.1.113883.3.464.1003.118.12.1035,Counseling for Physical Activity,20140701
2.16.840.1.113883.3.464.1003.120.12.1001,Disorders of the Immune System,20140701
2.16.840.1.113883.3.464.1003.120.12.1002,HIV Viral Load,20140701
2.16.840.1.113883.3.464.1003.120.12.1003,HIV,20140701
2.16.840.1.113883.3.464.1003.121.12.1004,CD4+ Count,20140701
2.16.840.1.113883.3.464.1003.121.12.1005,CD4+ Percentage,20140701
2.16.840.1.113883.3.464.1003.121.12.1006,Consultant Report,20140701
2.16.840.1.113883.3.464.1003.121.12.1012,BMI percentile,20140701
2.16.840.1.113883.3.464.1003.121.12.1013,Delta systolic blood pressure,20140701
2.16.840.1.113883.3.464.1003.121.12.1014,Height,20140701
2.16.840.1.113883.3.464.1003.121.12.1015,Weight,20140701
2.16.840.1.113883.3.464.1003.121.12.1016,Positive Finding,20140701
2.16.840.1.113883.3.464.1003.122.12.1003,Ambulatory,20140701
2.16.840.1.113883.3.464.1003.125.12.1002,Fluoride Varnish Application for Children,20140701
2.16.840.1.113883.3.464.1003.125.12.1003,Clinical Oral Evaluation,20140701
2.16.840.1.113883.3.464.1003.125.12.1004,Dental Caries,20140701
2.16.840.1.113883.3.464.1003.195.12.1002,Negative Finding,20140701
2.16.840.1.113883.3.464.1003.195.12.1003,Counseling for Nutrition,20140701
2.16.840.1.113883.3.464.1003.196.12.1001,Antibiotic Medications for Pharyngitis,20140701
2.16.840.1.113883.3.464.1003.196.12.1076,Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis,20140701
2.16.840.1.113883.3.464.1003.196.12.1080,Contraceptive Medications,20140701
2.16.840.1.113883.3.464.1003.196.12.1143,Isotretinoin,20140701
2.16.840.1.113883.3.464.1003.196.12.1170,Varicella Zoster Vaccine (VZV),20140701
2.16.840.1.113883.3.464.1003.196.12.1171,ADHD Medications,20140701
2.16.840.1.113883.3.464.1003.196.12.1202,Dapsone and pyrimethamine,20140701
2.16.840.1.113883.3.464.1003.196.12.1205,Leucovorin,20140701
2.16.840.1.113883.3.464.1003.196.12.1211,Aspirin and Other Anti-thrombotics,20140701
2.16.840.1.113883.3.464.1003.196.12.1212,Preferred Asthma Therapy,20140701
2.16.840.1.113883.3.464.1003.196.12.1213,Antidepressant Medication,20140701
2.16.840.1.113883.3.464.1003.196.12.1214,DTaP Vaccine,20140701
2.16.840.1.113883.3.464.1003.196.12.1215,Hepatitis A Vaccine,20140701
2.16.840.1.113883.3.464.1003.196.12.1216,Hepatitis B Vaccine,20140701
2.16.840.1.113883.3.464.1003.196.12.1217,Hemophilus Influenze B (HiB) Vaccine,20140701
2.16.840.1.113883.3.464.1003.196.12.1218,Influenza Vaccine,20140701
2.16.840.1.113883.3.464.1003.196.12.1219,Inactivated Polio Vaccine (IPV),20140701
2.16.840.1.113883.3.464.1003.196.12.1221,Pneumococcal Conjugate Vaccine,20140701
2.16.840.1.113883.3.464.1003.196.12.1222,Rotavirus Vaccine (2 dose schedule),20140701
2.16.840.1.113883.3.464.1003.196.12.1223,Rotavirus Vaccine (3 dose schedule),20140701
2.16.840.1.113883.3.464.1003.196.12.1224,"Measles, Mumps and Rubella (MMR) Vaccine",20140701
2.16.840.1.113883.3.464.1003.196.12.1253,High Risk Medications for the Elderly,20140701
2.16.840.1.113883.3.464.1003.196.12.1254,High-Risk Medications With Days Supply Criteria,20140701
2.16.840.1.113883.3.464.1003.198.12.1005,Bilateral Mastectomy,20140701
2.16.840.1.113883.3.464.1003.198.12.1006,Primary THA Procedure,20140701
2.16.840.1.113883.3.464.1003.198.12.1007,Primary TKA Procedure,20140701
2.16.840.1.113883.3.464.1003.198.12.1010,Flexible Sigmoidoscopy,20140701
2.16.840.1.113883.3.464.1003.198.12.1011,Fecal Occult Blood Test (FOBT),20140701
2.16.840.1.113883.3.464.1003.198.12.1012,Group A Streptococcus Test,20140701
2.16.840.1.113883.3.464.1003.198.12.1013,HbA1c Laboratory Test,20140530
2.16.840.1.113883.3.464.1003.198.12.1014,Hysterectomy with No Residual Cervix,20140701
2.16.840.1.113883.3.464.1003.198.12.1019,Total Colectomy,20140701
2.16.840.1.113883.3.464.1003.198.12.1020,Unilateral Mastectomy,20140701
2.16.840.1.113883.3.464.1003.198.12.1028,Mumps Antigen Test,20140701
2.16.840.1.113883.3.464.1003.198.12.1029,Measles Antigen Test,20140701
2.16.840.1.113883.3.464.1003.198.12.1030,Rubella Antigen Test,20140701
2.16.840.1.113883.3.464.1003.198.12.1031,Hepatitis B Antigen Test,20140701
2.16.840.1.113883.3.464.1003.198.12.1032,Varicella Zoster Antigen Test,20140701
2.16.840.1.113883.3.464.1003.198.12.1033,Hepatitis A Antigen Test,20140701
2.16.840.1.113883.3.464.1003.198.12.1034,X-Ray Study (all inclusive),20140701
2.16.840.1.113883.3.464.1003.199.12.1021,Anaphylactic Reaction to Rotavirus Vaccine,20140701
2.16.840.1.113883.3.464.1003.199.12.1022,Anaphylactic Reaction to Influenza Vaccine,20140701
2.16.840.1.113883.3.464.1003.199.12.1023,Anaphylactic Reaction to Inactivated Polio Vaccine (IPV),20140701
2.16.840.1.113883.3.464.1003.199.12.1024,Anaphylactic Reaction to Neomycin,20140701
2.16.840.1.113883.3.464.1003.199.12.1025,Anaphylactic Reaction to Polymyxin,20140701
2.16.840.1.113883.3.464.1003.199.12.1026,Anaphylactic Reaction to Hepatitis A Vaccine,20140701
2.16.840.1.113883.3.464.1003.199.12.1027,Anaphylactic Reaction to Pneumococcal Conjugate Vaccine,20140701
2.16.840.1.113883.3.464.1003.199.12.1028,Anaphylactic Reaction to Streptomycin,20140701
2.16.840.1.113883.3.464.1003.199.12.1029,Anaphylactic Reaction to Hepatitis B Vaccine,20140701
2.16.840.1.113883.3.464.1003.199.12.1030,Anaphylactic Reaction to Hemophilus Influenza B (HiB) Vaccine,20140701
2.16.840.1.113883.3.464.1003.199.12.1031,Anaphylactic Reaction to DTaP Vaccine,20140701
2.16.840.1.113883.3.464.1003.199.12.1032,Anaphylactic Reaction to Common Baker's Yeast,20140701
2.16.840.1.113883.3.464.1.49,BH Outpatient encounter,20140701
2.16.840.1.113883.3.526.2.1044,Systolic Blood Pressure,20140530
2.16.840.1.113883.3.526.2.1045,Diastolic Blood Pressure,20140530
2.16.840.1.113883.3.526.2.643,Clinical Trial Participant,20140401
2.16.840.1.113883.3.526.3.1002,"Chronic Kidney Disease, Stage 5",20140701
2.16.840.1.113883.3.526.3.1003,Proteinuria,20140701
2.16.840.1.113883.3.526.3.1005,Dementia & Mental Degenerations,20140701
2.16.840.1.113883.3.526.3.1006,Standardized Tools for Assessment of Cognition,20140701
2.16.840.1.113883.3.526.3.1007,Medical Reason,20140701
2.16.840.1.113883.3.526.3.1008,Patient Reason,20140701
2.16.840.1.113883.3.526.3.1009,System Reason,20140701
2.16.840.1.113883.3.526.3.1010,Cancer,20140701
2.16.840.1.113883.3.526.3.1011,Occupational Therapy Evaluation,20140701
2.16.840.1.113883.3.526.3.1012,Patient Provider Interaction,20140701
2.16.840.1.113883.3.526.3.1018,Psych Visit - Family Psychotherapy,20140701
2.16.840.1.113883.3.526.3.1020,Health & Behavioral Assessment - Individual,20140701
2.16.840.1.113883.3.526.3.1023,Behavioral/Neuropsych Assessment,20140701
2.16.840.1.113883.3.526.3.1024,Palliative Care,20140701
2.16.840.1.113883.3.526.3.1025,Severe Dementia,20140701
2.16.840.1.113883.3.526.3.1026,Radiation Treatment Management,20140701
2.16.840.1.113883.3.526.3.1027,Chemotherapy Administration,20140701
2.16.840.1.113883.3.526.3.1028,Standardized Pain Assessment Tool,20140701
2.16.840.1.113883.3.526.3.1032,Systolic Blood Pressure,20140701
2.16.840.1.113883.3.526.3.1033,Diastolic Blood Pressure,20140701
2.16.840.1.113883.3.526.3.1083,Hemodialysis,20140701
2.16.840.1.113883.3.526.3.1084,Peritoneal Dialysis,20140701
2.16.840.1.113883.3.526.3.1090,Moderate or Severe LVSD,20140701
2.16.840.1.113883.3.526.3.1091,Left Ventricular Systolic Dysfunction,20140701
2.16.840.1.113883.3.526.3.1092,Moderate or Severe,20140701
2.16.840.1.113883.3.526.3.1098,Clinical Staging Procedure,20140701
2.16.840.1.113883.3.526.3.1125,Clinical Trial Participant,20140701
2.16.840.1.113883.3.526.3.1134,Ejection Fraction,20140701
2.16.840.1.113883.3.526.3.1139,ACE Inhibitor or ARB,20140701
2.16.840.1.113883.3.526.3.1140,Patient Reason for ACE Inhibitor or ARB Decline,20140701
2.16.840.1.113883.3.526.3.1141,Psychoanalysis,20140701
2.16.840.1.113883.3.526.3.1151,Renal Failure Due to ACE Inhibitor,20140701
2.16.840.1.113883.3.526.3.1164,Breast Cancer Primary Tumor Size T1a,20140701
2.16.840.1.113883.3.526.3.1170,Tobacco User,20140701
2.16.840.1.113883.3.526.3.1174,Beta Blocker Therapy,20140701
2.16.840.1.113883.3.526.3.1176,Heart Rate,20140701
2.16.840.1.113883.3.526.3.1177,Allergy to Beta Blocker Therapy,20140701
2.16.840.1.113883.3.526.3.1178,Intolerance to Beta Blocker Therapy,20140701
2.16.840.1.113883.3.526.3.1184,Beta Blocker Therapy for LVSD,20140701
2.16.840.1.113883.3.526.3.1185,Previous Receipt of Influenza Vaccine,20140701
2.16.840.1.113883.3.526.3.1187,Group Psychotherapy,20140701
2.16.840.1.113883.3.526.3.1189,Tobacco Non-User,20140701
2.16.840.1.113883.3.526.3.1190,Tobacco Use Cessation Pharmacotherapy,20140701
2.16.840.1.113883.3.526.3.1193,Cardiac Pacer,20140701
2.16.840.1.113883.3.526.3.1197,Breast Cancer Primary Tumor Size T1mi,20140701
2.16.840.1.113883.3.526.3.1211,Allergy to ACE Inhibitor or ARB,20140701
2.16.840.1.113883.3.526.3.1212,Intolerance to ACE Inhibitor or ARB,20140701
2.16.840.1.113883.3.526.3.1240,Annual Wellness Visit,20140530
2.16.840.1.113883.3.526.3.1241,Acute and Subacute Iridocyclitis,20140701
2.16.840.1.113883.3.526.3.1245,Health and Behavioral Assessment - Initial,20140701
2.16.840.1.113883.3.526.3.1248,LDL-C Laboratory Test,20140701
2.16.840.1.113883.3.526.3.1251,Macular Exam,20140701
2.16.840.1.113883.3.526.3.1252,Encounter-Influenza,20140701
2.16.840.1.113883.3.526.3.1253,Allergy to Eggs,20140701
2.16.840.1.113883.3.526.3.1254,Influenza Vaccine,20140701
2.16.840.1.113883.3.526.3.1255,Influenza Vaccination Declined,20140701
2.16.840.1.113883.3.526.3.1256,Allergy to Influenza Vaccine,20140701
2.16.840.1.113883.3.526.3.1257,Intolerance to Influenza Vaccine,20140701
2.16.840.1.113883.3.526.3.1259,Limited Life Expectancy,20140701
2.16.840.1.113883.3.526.3.1270,Breast Cancer Primary Tumor Size T1b,20140701
2.16.840.1.113883.3.526.3.1278,Tobacco Use Screening,20140701
2.16.840.1.113883.3.526.3.1279,ECOG Performance Status-Poor,20140701
2.16.840.1.113883.3.526.3.1280,Allergy to Antineoplastic Therapy,20140701
2.16.840.1.113883.3.526.3.1283,Level of Severity of Retinopathy Findings,20140701
2.16.840.1.113883.3.526.3.1284,Macular Edema Findings Absent,20140701
2.16.840.1.113883.3.526.3.1285,Ophthalmological Services,20140701
2.16.840.1.113883.3.526.3.1287,Intolerance to Antineoplastic Therapy,20140701
2.16.840.1.113883.3.526.3.1288,Chemotherapy for Colon Cancer - Capecitabine,20140701
2.16.840.1.113883.3.526.3.1289,Chemotherapy for Colon Cancer - Fluorouracil,20140701
2.16.840.1.113883.3.526.3.1290,Chemotherapy for Colon Cancer - Leucovorin and Levo-Leucovorin,20140701
2.16.840.1.113883.3.526.3.1291,Chemotherapy for Colon Cancer - Oxaliplatin,20140701
2.16.840.1.113883.3.526.3.1292,Colon Cancer Primary Tumor Size T1,20140701
2.16.840.1.113883.3.526.3.1293,Colon Cancer Primary Tumor Size T2,20140701
2.16.840.1.113883.3.526.3.1294,Colon Cancer Primary Tumor Size T3,20140701
2.16.840.1.113883.3.526.3.1295,Colon Cancer Primary Tumor Size T4a,20140701
2.16.840.1.113883.3.526.3.1296,Colon Cancer Primary Tumor Size T4b,20140701
2.16.840.1.113883.3.526.3.1297,Colon Cancer Regional Lymph Node Status N1,20140701
2.16.840.1.113883.3.526.3.1298,Colon Cancer Regional Lymph Node Status N1c,20140701
2.16.840.1.113883.3.526.3.1299,Colon Cancer Regional Lymph Node Status N2,20140701
2.16.840.1.113883.3.526.3.1300,Colon Cancer Regional Lymph Node Status N2a,20140701
2.16.840.1.113883.3.526.3.1301,Colon Cancer Regional Lymph Node Status N2b,20140701
2.16.840.1.113883.3.526.3.1302,Breast Distant Metastasis Status M0,20140701
2.16.840.1.113883.3.526.3.1303,Breast Cancer ER or PR Positive,20140701
2.16.840.1.113883.3.526.3.1304,Breast Cancer Primary Tumor Size T0,20140701
2.16.840.1.113883.3.526.3.1305,Breast Cancer Primary Tumor Size T1,20140701
2.16.840.1.113883.3.526.3.1306,Breast Cancer Primary Tumor Size T1c,20140701
2.16.840.1.113883.3.526.3.1307,Breast Cancer Primary Tumor Size T2,20140701
2.16.840.1.113883.3.526.3.1308,Breast Cancer Primary Tumor Size T3,20140701
2.16.840.1.113883.3.526.3.1309,Breast Cancer Primary Tumor Size T4,20140701
2.16.840.1.113883.3.526.3.1310,Breast Cancer Regional Lymph Node Status N0,20140701
2.16.840.1.113883.3.526.3.1311,Breast Cancer Regional Lymph Node Status pN1a,20140701
2.16.840.1.113883.3.526.3.1312,Breast Cancer Regional Lymph Node Status pN1mi,20140701
2.16.840.1.113883.3.526.3.1313,Breast Cancer Regional Lymph Node Status N2,20140701
2.16.840.1.113883.3.526.3.1314,Breast Cancer Regional Lymph Node Status N3,20140701
2.16.840.1.113883.3.526.3.1315,Tamoxifen or Aromatase Inhibitor Therapy,20140701
2.16.840.1.113883.3.526.3.1316,Gonadotropin-Releasing Hormone Analogue Medication,20140701
2.16.840.1.113883.3.526.3.1317,Allergy to Tamoxifen or Aromatase Inhibitor Therapy,20140701
2.16.840.1.113883.3.526.3.1318,Intolerance to Tamoxifen or Aromatase Inhibitor Therapy,20140701
2.16.840.1.113883.3.526.3.1320,Macular Edema Findings Present,20140701
2.16.840.1.113883.3.526.3.1325,Prostate Cancer Primary Tumor Size T1c,20140701
2.16.840.1.113883.3.526.3.1326,Prostate Cancer Primary Tumor Size T2a,20140701
2.16.840.1.113883.3.526.3.1327,Colon Cancer Regional Lymph Node Status N1a,20140701
2.16.840.1.113883.3.526.3.1328,Colon Cancer Regional Lymph Node Status N1b,20140701
2.16.840.1.113883.3.526.3.1329,Breast Cancer Regional Lymph Node Status N1,20140701
2.16.840.1.113883.3.526.3.1480,Other Proliferative Retinopathy,20140701
2.16.840.1.113883.3.526.3.1330,Breast Cancer Regional Lymph Node Status pN1b,20140701
2.16.840.1.113883.3.526.3.1331,Breast Cancer Regional Lymph Node Status pN1c,20140701
2.16.840.1.113883.3.526.3.1332,Cognitive Assessment,20140701
2.16.840.1.113883.3.526.3.1333,Cup to Disc Ratio,20140701
2.16.840.1.113883.3.526.3.1334,Optic Disc Exam for Structural Abnormalities,20140701
2.16.840.1.113883.3.526.3.1337,Colon Distant Metastasis Status M0,20140701
2.16.840.1.113883.3.526.3.1339,Radiation Therapy II,20140701
2.16.840.1.113883.3.526.3.1405,Adhesions and Disruptions of Iris and Ciliary Body,20140701
2.16.840.1.113883.3.526.3.1406,Anomalies of Puillary Function,20140701
2.16.840.1.113883.3.526.3.1407,Aphakia and Other Disorders of Lens,20140701
2.16.840.1.113883.3.526.3.1408,Aspiration and Injection Procedures,20140701
2.16.840.1.113883.3.526.3.1409,Burn Confined to Eye and Adnexa,20140701
2.16.840.1.113883.3.526.3.1410,Cataract Secondary to Ocular Disorders,20140701
2.16.840.1.113883.3.526.3.1411,Cataract Surgery,20140701
2.16.840.1.113883.3.526.3.1412,"Cataract, Congenital",20140701
2.16.840.1.113883.3.526.3.1413,"Cataract, Mature or Hypermature",20140701
2.16.840.1.113883.3.526.3.1414,"Cataract, Posterior Polar",20140701
2.16.840.1.113883.3.526.3.1415,Certain Types of Iridocyclitis,20140701
2.16.840.1.113883.3.526.3.1416,Chronic Iridocyclitis,20140701
2.16.840.1.113883.3.526.3.1417,Cloudy Cornea,20140701
2.16.840.1.113883.3.526.3.1418,Corneal Edema,20140701
2.16.840.1.113883.3.526.3.1419,Corneal Opacity and Other Disorders of Cornea,20140701
2.16.840.1.113883.3.526.3.1420,"Cysts of Iris, Ciliary Body, and Anterior Chamber",20140701
2.16.840.1.113883.3.526.3.1421,Enophthalmos,20140701
2.16.840.1.113883.3.526.3.1422,Excision of Adhesions,20140701
2.16.840.1.113883.3.526.3.1423,Glaucoma,20140701
2.16.840.1.113883.3.526.3.1424,Hereditary Corneal Dystrophies,20140701
2.16.840.1.113883.3.526.3.1425,High Hyperopia,20140701
2.16.840.1.113883.3.526.3.1426,Hypotony of Eye,20140701
2.16.840.1.113883.3.526.3.1427,Injury to Optic Nerve and Pathways,20140701
2.16.840.1.113883.3.526.3.1428,Central Corneal Ulcer,20140701
2.16.840.1.113883.3.526.3.1429,Lens Procedure,20140701
2.16.840.1.113883.3.526.3.1430,Open Wound of Eyeball,20140701
2.16.840.1.113883.3.526.3.1432,Pathologic Myopia,20140701
2.16.840.1.113883.3.526.3.1433,Posterior Lenticonus,20140701
2.16.840.1.113883.3.526.3.1434,Prior Pars Plana Vitrectomy,20140701
2.16.840.1.113883.3.526.3.1435,Pseudoexfoliation Syndrome,20140701
2.16.840.1.113883.3.526.3.1436,Removal Procedures,20140701
2.16.840.1.113883.3.526.3.1437,Retinal Repair Procedures,20140701
2.16.840.1.113883.3.526.3.1438,Retrolental Fibroplasias,20140701
2.16.840.1.113883.3.526.3.1439,Revision Procedures,20140701
2.16.840.1.113883.3.526.3.1440,Scleral Procedures,20140701
2.16.840.1.113883.3.526.3.1441,Senile Cataract,20140701
2.16.840.1.113883.3.526.3.1442,Use of Systemic Sympathetic alpha-1a Antagonist Medication for Treatment of Prostatic Hypertrophy,20140701
2.16.840.1.113883.3.526.3.1443,Traumatic Cataract,20140701
2.16.840.1.113883.3.526.3.1444,Uveitis,20140701
2.16.840.1.113883.3.526.3.1445,Vascular Disorders of Iris and Ciliary Body,20140701
2.16.840.1.113883.3.526.3.1446,Visual Field Defects,20140701
2.16.840.1.113883.3.526.3.1447,Vitreous Procedures,20140701
2.16.840.1.113883.3.526.3.1448,Amblyopia,20140701
2.16.840.1.113883.3.526.3.1449,Chorioretinal Scars,20140701
2.16.840.1.113883.3.526.3.1450,Choroidal Degenerations,20140701
2.16.840.1.113883.3.526.3.1451,Choroidal Detachment,20140701
2.16.840.1.113883.3.526.3.1452,Choroidal Hemorrhage and Rupture,20140701
2.16.840.1.113883.3.526.3.1453,Degeneration of Macula and Posterior Pole,20140701
2.16.840.1.113883.3.526.3.1454,Degenerative Disorders of Globe,20140701
2.16.840.1.113883.3.526.3.1455,Diabetic Macular Edema,20140701
2.16.840.1.113883.3.526.3.1457,Disorders of Optic Chiasm,20140701
2.16.840.1.113883.3.526.3.1458,Disorders of Visual Cortex,20140701
2.16.840.1.113883.3.526.3.1459,Disseminated Chorioretinitis and Disseminated Retinochoroiditis,20140701
2.16.840.1.113883.3.526.3.1460,Focal Chorioretinitis and Focal Retinochoroiditis,20140701
2.16.840.1.113883.3.526.3.1461,"Glaucoma Associated with Congenital Anomalies, Dystrophies, and Systemic Syndromes",20140701
2.16.840.1.113883.3.526.3.1462,Hereditary Choroidal Dystrophies,20140701
2.16.840.1.113883.3.526.3.1463,Hereditary Retinal Dystrophies,20140701
2.16.840.1.113883.3.526.3.1464,"Moderate or Severe Impairment, Better Eye, Profound Impairment Lesser Eye",20140701
2.16.840.1.113883.3.526.3.1465,Nystagmus and Other Irregular Eye Movements,20140701
2.16.840.1.113883.3.526.3.1466,Optic Atrophy,20140701
2.16.840.1.113883.3.526.3.1467,Optic Neuritis,20140701
2.16.840.1.113883.3.526.3.1468,Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis,20140701
2.16.840.1.113883.3.526.3.1469,Other Background Retinopathy and Retinal Vascular Changes,20140701
2.16.840.1.113883.3.526.3.1470,Other Corneal Deformities,20140701
2.16.840.1.113883.3.526.3.1471,Other Disorders of Optic Nerve,20140701
2.16.840.1.113883.3.526.3.1472,Other Disorders of Sclera,20140701
2.16.840.1.113883.3.526.3.1473,Other Endophthalmitis,20140701
2.16.840.1.113883.3.526.3.1474,Other Retinal Disorders,20140701
2.16.840.1.113883.3.526.3.1475,Prior Penetrating Keratoplasty,20140701
2.16.840.1.113883.3.526.3.1476,"Profound Impairment, Both Eyes",20140701
2.16.840.1.113883.3.526.3.1477,Purulent Endophthalmitis,20140701
2.16.840.1.113883.3.526.3.1478,Retinal Detachment with Retinal Defect,20140701
2.16.840.1.113883.3.526.3.1479,Retinal Vascular Occlusion,20140701
2.16.840.1.113883.3.526.3.1481,Scleritis and Episcleritis,20140701
2.16.840.1.113883.3.526.3.1482,Separation of Retinal Layers,20140701
2.16.840.1.113883.3.526.3.1483,Visual Acuity 20/40 or Better,20140701
2.16.840.1.113883.3.526.3.1484,Suicide Risk Assessment,20140701
2.16.840.1.113883.3.526.3.1485,Chemotherapy for Colon Cancer - Capecitabine Ingredient,20140701
2.16.840.1.113883.3.526.3.1486,Chemotherapy for Colon Cancer - Fluorouracil Ingredient,20140701
2.16.840.1.113883.3.526.3.1487,Tamoxifen or Aromatase Inhibitor Therapy Ingredient,20140701
2.16.840.1.113883.3.526.3.1488,Best Corrected Visual Acuity,20140701
2.16.840.1.113883.3.526.3.1489,ACE Inhibitor or ARB Ingredient,20140701
2.16.840.1.113883.3.526.3.1490,Chemotherapy for Colon Cancer - Leucovorin and Levo-Leucovorin Ingredient,20140701
2.16.840.1.113883.3.526.3.1491,Major Depressive Disorder-Active,20140701
2.16.840.1.113883.3.526.3.1492,Psych Visit - Diagnostic Evaluation,20140701
2.16.840.1.113883.3.526.3.1493,Beta Blocker Therapy Ingredient,20140701
2.16.840.1.113883.3.526.3.1494,Reason Documented,20140701
2.16.840.1.113883.3.526.3.1495,Chemotherapy for Colon Cancer - Oxaliplatin Ingredient,20140701
2.16.840.1.113883.3.526.3.1496,Psych Visit - Psychotherapy,20140701
2.16.840.1.113883.3.526.3.319,Prostate Cancer,20140701
2.16.840.1.113883.3.526.3.320,Bone Scan,20140701
2.16.840.1.113883.3.526.3.326,Primary Open-Angle Glaucoma,20140701
2.16.840.1.113883.3.526.3.327,Diabetic Retinopathy,20140701
2.16.840.1.113883.3.526.3.353,End Stage Renal Disease,20140701
2.16.840.1.113883.3.526.3.362,Asthma,20140701
2.16.840.1.113883.3.526.3.366,Arrhythmia,20140701
2.16.840.1.113883.3.526.3.367,Atrioventricular Block,20140701
2.16.840.1.113883.3.526.3.368,Cardiac Pacer in Situ,20140701
2.16.840.1.113883.3.526.3.369,Coronary Artery Disease No MI,20140701
2.16.840.1.113883.3.526.3.370,Hypotension,20140701
2.16.840.1.113883.3.526.3.371,Cardiac Surgery,20140701
2.16.840.1.113883.3.526.3.376,Heart Failure,20140701
2.16.840.1.113883.3.526.3.378,Pregnancy,20140701
2.16.840.1.113883.3.526.3.389,Breast Cancer,20140701
2.16.840.1.113883.3.526.3.391,Colon Cancer,20140701
2.16.840.1.113883.3.526.3.397,Gleason Score,20140701
2.16.840.1.113883.3.526.3.398,Prostate Cancer Treatment,20140701
2.16.840.1.113883.3.526.3.399,Salvage Therapy,20140701
2.16.840.1.113883.3.526.3.401,Prostate Specific Antigen Test,20140701
2.16.840.1.113883.3.526.3.402,Influenza Vaccination,20140701
2.16.840.1.113883.3.526.3.403,Myocardial Infarction,20140701
2.16.840.1.113883.3.526.3.412,Bradycardia,20140701
2.16.840.1.113883.3.526.3.447,Metastatic Sites Common to Breast Cancer,20140701
2.16.840.1.113883.3.526.3.451,Pain Related to Prostate Cancer,20140701
2.16.840.1.113883.3.526.3.471,Bilateral Oophorectomy,20140701
2.16.840.1.113883.3.526.3.485,Chemotherapy,20140701
2.16.840.1.113883.3.526.3.490,Metastatic Sites Common to Colon Cancer,20140701
2.16.840.1.113883.3.526.3.509,Tobacco Use Cessation Counseling,20140701
2.16.840.1.113883.3.560.100.1,Male,20140701
2.16.840.1.113883.3.560.100.2,Female,20140701
2.16.840.1.113883.3.560.100.4,birth date,20140530
2.16.840.1.113883.3.600.1.1498,Above Normal Medications,20140701
2.16.840.1.113883.3.600.1.1499,Below Normal Medications,20140701
2.16.840.1.113883.3.600.1.1502,Medical or Other reason not done,20140701
2.16.840.1.113883.3.600.1.1503,Patient Reason Refused,20140701
2.16.840.1.113883.3.600.1.1525,Above Normal Follow-up,20140701
2.16.840.1.113883.3.600.1.1527,Referrals where weight assessment may occur,20140701
2.16.840.1.113883.3.600.1.1528,Below Normal Follow up,20140701
2.16.840.1.113883.3.600.1.1579,Palliative Care,20140701
2.16.840.1.113883.3.600.1.1623,Pregnancy Dx,20140701
2.16.840.1.113883.3.600.1.1751,BMI Encounter Code Set,20140701
2.16.840.1.113883.3.600.1.1834,Medications Encounter Code Set,20140701
2.16.840.1.113883.3.600.145,Depression diagnosis,20140701
2.16.840.1.113883.3.600.1.462,Current Medications Documented SNMD,20140701
2.16.840.1.113883.3.600.1474,Followup within one year,20140701
2.16.840.1.113883.3.600.1475,Referral to Alternative Provider / Primary Care Provider,20140701
2.16.840.1.113883.3.600.1476,Anti-Hypertensive Pharmacologic Therapy,20140701
2.16.840.1.113883.3.600.1482,Laboratory Tests for Hypertension,20140701
2.16.840.1.113883.3.600.1508,Lifestyle Recommendation,20140701
2.16.840.1.113883.3.600.1510,Weight Reduction Recommended,20140701
2.16.840.1.113883.3.600.1515,Dietary Recommendations,20140701
2.16.840.1.113883.3.600.1518,Physical Activity Recommendation,20140701
2.16.840.1.113883.3.600.1521,Medical reason,20140701
2.16.840.1.113883.3.600.1537,Followup within 4 weeks,20140701
2.16.840.1.113883.3.600.1542,Additional evaluation for depression - adolescent,20140701
2.16.840.1.113883.3.600.1545,Additional evaluation for depression - adult,20140701
2.16.840.1.113883.3.600.1557,Family History CHD,20140701
2.16.840.1.113883.3.600.1561,Framingham coronary heart disease 10 year risk,20140701
2.16.840.1.113883.3.600.1622,Pregnancy,20140701
2.16.840.1.113883.3.600.1.681,BMI LOINC Value,20140701
2.16.840.1.113883.3.600.1916,Depression Screening Denominator Encounter Codes New,20140701
2.16.840.1.113883.3.600.1920,BP Screening Denominator Encounter Codes Grouped New,20140701
2.16.840.1.113883.3.600.1951,Cholesterol Measure Encounter Codes,20140701
2.16.840.1.113883.3.600.2387,Overweight,20140701
2.16.840.1.113883.3.600.2388,Underweight,20140701
2.16.840.1.113883.3.600.2390,Current Cigarette Smoker,20140701
2.16.840.1.113883.3.600.2395,Finding of Hypertension,20140701
2.16.840.1.113883.3.600.2448,ECG 12 lead or study order,20140701
2.16.840.1.113883.3.600.2449,Adult Depression Screening,20140701
2.16.840.1.113883.3.600.2450,Positive Depression Screening,20140701
2.16.840.1.113883.3.600.2451,Negative Depression Screening,20140701
2.16.840.1.113883.3.600.2452,Adolescent Depression Screening,20140701
2.16.840.1.113883.3.600.2454,Depression Screening Result,20140701
2.16.840.1.113883.3.600.263,Diagnosis of hypertension grouped,20140701
2.16.840.1.113883.3.600.450,Bipolar Diagnosis,20140701
2.16.840.1.113883.3.600.467,Follow-up for depression - adolescent,20140701
2.16.840.1.113883.3.600.468,Follow-up for depression - adult,20140701
2.16.840.1.113883.3.600.469,Depression medications - adolescent,20140701
2.16.840.1.113883.3.600.470,Depression medications - adult,20140701
2.16.840.1.113883.3.600.537,Referral for Depression Adolescent,20140701
2.16.840.1.113883.3.600.538,Referral for Depression Adult,20140701
2.16.840.1.113883.3.600.559,Suicide Risk Assessment,20140701
2.16.840.1.113883.3.600.791,Patient Reason refused,20140701
2.16.840.1.113883.3.600.792,Medical reason contraindicated,20140701
2.16.840.1.113883.3.600.823,Moderation of ETOH Consumption Recommendation,20140701
2.16.840.1.113883.3.600.863,CHD or CHD Risk Equivalent,20140701
2.16.840.1.113883.3.600.872,LDL Code,20140701
2.16.840.1.113883.3.600.875,High Density Lipoprotein (HDL),20140701
2.16.840.1.113883.3.600.879,Total Cholesterol,20140701
2.16.840.1.113883.3.600.883,Triglycerides,20140701
2.16.840.1.113883.3.666.5.1058,Hospital Measures-Beta lactams for allergy determination,20140401
2.16.840.1.113883.3.666.5.1108,Hospital measures-Route IV,20140401
2.16.840.1.113883.3.666.5.1109,Hospital Measures-Route IV/IM,20140401
2.16.840.1.113883.3.666.5.1111,"Hospital measures-Route IV, oral or IM",20140401
2.16.840.1.113883.3.666.5.1112,Hospital Measures-Route IV or PO,20140401
2.16.840.1.113883.3.666.5.1145,Hospital Measures - Hold,20140401
2.16.840.1.113883.3.666.5.1151,Hospital Measures-Aortic balloon pump insertion,20140401
2.16.840.1.113883.3.666.5.1566,Impaired Fetal Growth Group,20140401
2.16.840.1.113883.3.666.5.1567,Birth Trauma or Injuries Group,20140401
2.16.840.1.113883.3.666.5.1568,Newborn Affected by Placenta or Abruption Group,20140401
2.16.840.1.113883.3.666.5.1570,Congenital Anomalies Group,20140401
2.16.840.1.113883.3.666.5.1571,Hemolytic Disease Group,20140401
2.16.840.1.113883.3.666.5.1573,Hydrops Group,20140401
2.16.840.1.113883.3.666.5.1574,Drug Withdrawal Syndrome Group,20140401
2.16.840.1.113883.3.666.5.1576,Laryngeal Stenosis Group,20140401
2.16.840.1.113883.3.666.5.1577,Hypoxia or Asphyxia Group,20140401
2.16.840.1.113883.3.666.5.1580,Congenital or Infantile Cerebral Palsy Group,20140401
2.16.840.1.113883.3.666.5.1581,Shock and Complications Group,20140401
2.16.840.1.113883.3.666.5.1582,Arterial or Umbilical Venous Cath Group,20140401
2.16.840.1.113883.3.666.5.1583,TPN Procedure Group,20140401
2.16.840.1.113883.3.666.5.1584,Gastrostomy Group,20140401
2.16.840.1.113883.3.666.5.1585,Gavage Feeding Group,20140401
2.16.840.1.113883.3.666.5.1586,Cardiopulmonary Resuscitation Group,20140401
2.16.840.1.113883.3.666.5.1588,Respiratory Problems Group,20140401
2.16.840.1.113883.3.666.5.1589,Respiratory Procedures Group,20140401
2.16.840.1.113883.3.666.5.1590,Infection Group,20140401
2.16.840.1.113883.3.666.5.1591,Neurologic Complications Group,20140401
2.16.840.1.113883.3.666.5.1592,Neurologic Procedure Group,20140401
2.16.840.1.113883.3.666.5.1593,Hyperbilirubinemia Group,20140401
2.16.840.1.113883.3.666.5.1594,Phototherapy Procedure Group,20140401
2.16.840.1.113883.3.666.5.1595,Social Reasons Group,20140401
2.16.840.1.113883.3.666.5.1596,Gestational age >= 37 weeks,20140401
2.16.840.1.113883.3.666.5.1618,Neonatal Death SM-CT,20140401
2.16.840.1.113883.3.666.5.1726,Hospital Measures-Immunodeficient Conditions,20140401
2.16.840.1.113883.3.666.5.1741,Hospital measures-Pacemaker or implantable defibrillator insertion procedure,20140401
2.16.840.1.113883.3.666.5.1743,General or Neuraxial Anesthesia,20140401
2.16.840.1.113883.3.666.5.1816,Hospital measures-Knee arthroplasty,20140401
2.16.840.1.113883.3.666.5.1921,Hospital Measures-Caesarean Section,20140401
2.16.840.1.113883.3.666.5.1940,Hospital Measures-Immunocompromised Conditions,20140401
2.16.840.1.113883.3.666.5.2128,IV Positive Inotropic and Vasopressor Agents,20140401
2.16.840.1.113883.3.666.5.2129,Paralytic Agents,20140401
2.16.840.1.113883.3.666.5.2160,Hospital Measures-Restrictive lung disease,20140401
2.16.840.1.113883.3.666.5.2162,Hospital Measures-Respiratory infection,20140401
2.16.840.1.113883.3.666.5.2192,Hospital Measures-Wound Care,20140401
2.16.840.1.113883.3.666.5.2197,Hospital Measures-Prolonged QT Interval,20140401
2.16.840.1.113883.3.666.5.2202,Hospital Measures-Nursing Home or Ext Fac Transfer,20140401
2.16.840.1.113883.3.666.5.2203,Hospital Measures-IV Tigecycline,20140401
2.16.840.1.113883.3.666.5.2204,Hospital Measures-IV Tetracycline,20140401
2.16.840.1.113883.3.666.5.2205,Hospital Measures-Francisella Tularensis or Yersinia pestis,20140401
2.16.840.1.113883.3.666.5.2254,Hospital measures - Request of physician,20140401
2.16.840.1.113883.3.666.5.2256,Any Infection Prior to Anesthesia Concepts,20140401
2.16.840.1.113883.3.666.5.2275,Hospital Measures-Cardiac Valve Surgery,20140401
2.16.840.1.113883.3.666.5.2278,Hospital Measures-MRSA Colonization or Infection,20140401
2.16.840.1.113883.3.666.5.2282,Hospital measures-Hemodialysis or peritoneal dialysis,20140401
2.16.840.1.113883.3.666.5.2289,Hospital measures-Acute care hospital encounter,20140401
2.16.840.1.113883.3.666.5.2310,Hospital Measures-SCIP Urological/Perineal procedures with potential need of indwelling catheters,20140401
2.16.840.1.113883.3.666.5.2313,Hospital Measures-SCIP urinary diversion procedures,20140401
2.16.840.1.113883.3.666.5.2319,Hospital Measures-Respiratory failure acute or chronic,20140401
2.16.840.1.113883.3.666.5.2348,Hospital Measures-Immunocompromised Therapies,20140401
2.16.840.1.113883.3.666.5.2365,Hospital Measures-Radiologic Finding-Normal SM-CT,20140401
2.16.840.1.113883.3.666.5.2486,ICU Locations,20140401
2.16.840.1.113883.3.666.5.3006,Hospital Measures-ED Locations,20140401
2.16.840.1.113883.3.666.5.3011,Hospital Measures - AMI,20140401
2.16.840.1.113883.3.666.5.3013,Hospital Measures-Acute care hospital,20140401
2.16.840.1.113883.3.666.5.3015,Hospital Measures-Ventricular Assist Device placement,20140401
2.16.840.1.113883.3.666.5.3022,Hospital Measures-Acute or Evolving MI,20140401
2.16.840.1.113883.3.666.5.307,Encounter Inpatient,20140401
2.16.840.1.113883.3.666.5.463,Hospital Measures-IV PO Quinolone Antipneumococcal,20140401
2.16.840.1.113883.3.666.5.465,Hospital Measures-IV Quinolones Antipneumococcal,20140401
2.16.840.1.113883.3.666.5.626,Hospital Measures-Aspirin,20140401
2.16.840.1.113883.3.666.5.672,Hospital Measures-Septicemia,20140401
2.16.840.1.113883.3.666.5.678,Hospital Measures-Chest xray SM-CT,20140401
2.16.840.1.113883.3.666.5.680,Hospital Measures-CT scan including chest,20140401
2.16.840.1.113883.3.666.5.684,Hospital Measures-Acute care hospital,20140401
2.16.840.1.113883.3.666.5.687,Hospital Measures-Ambulatory surgical center,20140401
2.16.840.1.113883.3.666.5.693,"IV, IM, PO Antimicrobial Medications",20140401
2.16.840.1.113883.3.666.5.694,Hospital measures-CABG,20140401
2.16.840.1.113883.3.666.5.696,Hospital Measures - Any infection,20140401
2.16.840.1.113883.3.666.5.701,Hospital measures-Other Cardiac Surgery,20140401
2.16.840.1.113883.3.666.5.703,Hospital measures-Hip arthroplasty,20140401
2.16.840.1.113883.3.666.5.705,Hospital measures- Colon surgery,20140401
2.16.840.1.113883.3.666.5.708,Hospital Measures-IV Metronidazole,20140401
2.16.840.1.113883.3.666.5.710,Hospital measures-Abdominal hysterectomy,20140401
2.16.840.1.113883.3.666.5.712,Hospital measures-Vaginal hysterectomy,20140401
2.16.840.1.113883.3.666.5.713,Hospital measures-Vascular surgery,20140401
2.16.840.1.113883.3.666.5.719,Hospital Measures-Chronic Wound Care,20140401
2.16.840.1.113883.3.666.5.720,Hospital Measures-IV or IM Beta lactams,20140401
2.16.840.1.113883.3.666.5.724,Hospital Measures-IV Colon-Antibiotics,20140401
2.16.840.1.113883.3.666.5.725,Hospital Measures-IV Ertapenem,20140401
2.16.840.1.113883.3.666.5.727,Hospital Measures-IV Aminoglycosides,20140401
2.16.840.1.113883.3.666.5.728,Hospital Measures-IV Aztreonam,20140401
2.16.840.1.113883.3.666.5.729,Antibiotics for Prophylaxis for Hysterectomy Surgeries,20140401
2.16.840.1.113883.3.666.5.730,Expired,20140401
2.16.840.1.113883.3.666.5.735,Hospital Measures-ECG,20140401
2.16.840.1.113883.3.666.5.736,Hospital Measures-Fibrinolytic Therapy,20140401
2.16.840.1.113883.3.666.5.748,Hospital Measures-Cardiopulmonary arrest,20140401
2.16.840.1.113883.3.666.5.752,Hospital Measures-Pneumonia,20140401
2.16.840.1.113883.3.666.5.758,Hospital Measures-IV Macrolides ICU,20140401
2.16.840.1.113883.3.666.5.759,Hospital Measures-IV Antipneumococcal/antipseudomonal beta lactams,20140401
2.16.840.1.113883.3.666.5.760,Hospital Measures-IV or PO Levofloxacin,20140401
2.16.840.1.113883.3.666.5.765,IV Antimicrobial medication,20140401
2.16.840.1.113883.3.666.5.766,Hospital measures-IV Vancomycin,20140401
2.16.840.1.113883.3.666.5.767,Hospital Measures-IV Hysterectomy and Colon Quinolones,20140401
2.16.840.1.113883.3.666.5.768,Cefuroxime and Cefazolin Antibiotics for IV Administration,20140401
2.16.840.1.113883.3.666.5.770,Hospital Measures-IV Beta lactams,20140401
2.16.840.1.113883.3.666.5.772,Hospital Measures-IV or PO Macrolides Non-ICU,20140401
2.16.840.1.113883.3.666.5.773,Hospital Measures-Bronchiectasis,20140401
2.16.840.1.113883.3.666.5.774,Hospital Measures-Structural lung disease,20140401
2.16.840.1.113883.3.666.5.775,Hospital Measures-Chronic bronchitis,20140401
2.16.840.1.113883.3.666.5.776,Hospital Measures-COPD,20140401
2.16.840.1.113883.3.666.5.777,Hospital Measures-Interstital lung disease,20140401
2.16.840.1.113883.3.666.5.779,Hospital Measures-IV or IM Aztreonam,20140401
2.16.840.1.113883.3.666.5.782,Hospital Measures-Ventilator care,20140401
2.16.840.1.113883.3.666.5.783,Hospital Measures-Healthcare associated pneumonia,20140401
2.16.840.1.113883.3.666.5.787,Hospital Measures-Neutrophil count,20140401
2.16.840.1.113883.3.666.5.801,Hospital Measures-Organ transplant,20140401
2.16.840.1.113883.3.666.5.803,Hospital Measures-Systemic immunosuppressive therapy,20140401
2.16.840.1.113883.3.666.5.805,Hospital Measures-Systemic corticosteroid/prednisone therapy,20140401
2.16.840.1.113883.3.666.5.806,Hospital Measures-Emphysema,20140401
2.16.840.1.113883.3.666.5.822,Hospital Measures-SCIP urinary diversion,20140401
2.16.840.1.113883.3.666.5.825,Hospital Measures-Intermittent Catheterization,20140401
2.16.840.1.113883.3.666.5.827,Hospital Measures-Suprapubic catheter,20140401
2.16.840.1.113883.3.666.5.829,Hospital Measures-Diuretics RxNorm,20140401
2.16.840.1.113883.3.666.5.835,IV quinolones,20140401
2.16.840.1.113883.3.666.5.840,Hospital Measures-IV or PO Tetracyclines,20140401
2.16.840.1.113883.3.666.5.893,Hospital Measures-IV Clindamycin,20140401
2.16.840.1.113883.3.666.5.896,Hospital Measures-IV Antipseudomonal quinolones,20140401
2.16.840.1.113883.3.67.1.101.1.128,Bipolar Disorder,20140701
2.16.840.1.113883.3.67.1.101.11.721,Deceased,20140701
2.16.840.1.113883.3.67.1.101.11.723,PHQ-9 Tool,20140701
2.16.840.1.113883.3.67.1.101.1.246,Personality Disorder,20140701
2.16.840.1.113883.3.67.1.101.1.254,Dysthymia,20140701
2.16.840.1.113883.3.67.1.101.1.269,Hepatitis B,20140701
2.16.840.1.113883.3.67.1.101.1.278,Delivery - Diagnosis,20140701
2.16.840.1.113883.3.67.1.101.1.279,HBsAg,20140701
2.16.840.1.113883.3.67.1.101.950,Hospital Measures-Hospital outpatient department,20140401
2.16.840.1.114222.4.11.3591,Payer,20140530
2.16.840.1.114222.4.11.836,Race,20140530
2.16.840.1.114222.4.11.837,Ethnicity,20140530
2.16.840.1.114222.4.1.214079.1.1.1,Livebirth,20140401
2.16.840.1.114222.4.1.214079.1.1.3,Newborn Hearing Screen Left,20140401
2.16.840.1.114222.4.1.214079.1.1.4,Newborn Hearing Screen Right,20140401
2.16.840.1.114222.4.1.214079.1.1.6,Pass Or Refer,20140401
2.16.840.1.114222.4.1.214079.1.1.7,Medical Reasons,20140401
2.16.840.113883.3.67.1.101.3.2444,Major Depression Including Remission,20140701
2.16.840.113883.3.67.1.101.3.2445,Psych Visit,20140701
